We use cookies to help provide you with the best possible online experience. Please read our Privacy Policy for information about which cookies we use and what information we collect on our site. By continuing to use this site, you agree that we may store and access cookies on your device.

I Agree

You are here: Industry Insights > Recursion

News List

Recursion, Bayer Expand Strategic Fibrosis Alliance contractpharma
December 07, 2021
To leverage Recursion's inferential search capabilities based on maps of human cellular biology to accelerate work in fibrotic disease.
Recursion raises $239m and signs drug discovery deal with Bayer pharmaceutical-technology
September 24, 2020
Digital biology company Recursion Pharmaceuticals has secured $239m in a Series D financing round led by Leaps by Bayer, the impact investment arm of Bayer.
Bayer, Recursion Collaborate on Therapies for Fibrotic Diseases americanpharmaceuticalreview
September 16, 2020
Bayer and US-based Recursion Pharmaceuticals have entered into a strategic collaboration agreement.
Deals this week: Catalent Pharma Solutions, China Grand Pharmaceutical and Healthcare Holdings, Recu pharmaceufical-technology
October 16, 2017
US-based pharmaceutical company Catalent Pharma Solutions plans to raise $450m through the private placement of senior unsecured notes, due 2026.